Hosted by Evercores equity research analysts, Liisa Bayko and Umer Raffat, the panel featured notable obesity physicians Helena Rodbard, MD, FACP, MACE, and Sean Wharton, MD, PharmD
Other noteworthy phase 3 trial readouts in 2025 include: Novo Nordisks evoke/evoke+ , investigating oral semaglutide in patients with early Alzheimers disease, potentially expanding the utility of GLP-1s beyond cardiometabolic indications
No supplement replaces foundational lifestyle medicine, but when used appropriately and sourced responsibly, they can be powerful adjuncts in a comprehensive health strategy. Below, a few helpful guidelines on what to look for
GLP-1 receptor agonists increase resting heart rate
Understanding which medication you are taking and its associated incidence rate helps set realistic expectations and guides management decisions
L-Carnitin Tabletten Energiequelle und Leistungsfrderer L-Carnitin kann Deine sportlichen Ambitionen vorantreiben